SCP
LLY icon

Sender Company & Partners’s Eli Lilly LLY Stock Holding History

Sender Company & Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-14,700
Closed -$13.5M – 130
2026
Q1 		$13.5M Buy
+14,700
New +$14.9M 8.22% 3
2025
Q4 		– Sell
-900
Closed -$687K – 303
2025
Q3 		$687K Buy
+900
New +$670K 0.08% 221

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sender Company & Partners's LLY Position: Q2 2026 in Review

Sender Company & Partners reduced its Eli Lilly (LLY) stake by 3% in Q2 2026, selling an estimated $402K and leaving 12,607 shares worth $15.1M. The position accounts for 4.38% of the portfolio, ranked #5.

Sender Company & Partners first reported a position in LLY in Q3 2022 and has held it in 8 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Sender Company & Partners held 12,607 shares of Eli Lilly worth $15.1M as of Q2 2026.
  • Sender Company & Partners sold 393 Eli Lilly shares in Q2 2026, an estimated $402K.
  • Eli Lilly made up 4.38% of Sender Company & Partners's portfolio in Q2 2026, its #5 holding.
  • Sender Company & Partners first reported a position in Eli Lilly in Q3 2022 and has held it in 8 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Sender Company & Partners's 13F filing for Q2 2026, filed 14 Aug 2026.